Antibiotic levels in bronchial tree and in serum during selective digestive decontamination.
Selective digestive decontamination has been found to prevent pulmonary infections in mechanically ventilated patients. The aims of this study were: 1) to determine whether detectable levels of antibiotics could be found in bronchial tree secretions of patients receiving SDD, and 2) to evaluate antibiotic serum levels. In 15 patients receiving mechanical ventilation and SDD for 10 days or more, tobramycin and amphotericin B levels were determined every 3 days in the following specimens: tracheal aspirates, distal bronchial secretions and blood samples. 82% of tracheal aspirates contained detectable (greater than 0.18 mg/l), tobramycin concentrations; the levels varied widely between patients and large day-to-day variations were observed. Every patient had at least 1 tracheal aspirate with tobramycin level higher than 0.5 mg/l during his course. 40% of distal specimens contained detectable tobramycin levels (10 patients). Serum determinations showed detectable concentration of tobramycin in 50% of the specimens (9 patients). Two patients with renal failure had serum tobramycin levels higher than 2 mg/l. In 13 tracheal aspirates cultures were positive and 15 species were isolated; 13 had a MIC higher than the corresponding tobramycin level in tracheal secretions. We conclude that substantial levels of antibiotics can be found frequently in respiratory tract specimens of patients receiving SDD. Therefore, the usual microbiological criteria used to assess respiratory tract infection may be unreliable in this setting and other criteria may be required. Follow-up of antibiotic serum levels is required, especially in patients with renal failure.
Gastinne
H
H
Réanimation Polyvalente, Hôpital Universitaire Dupuytren, Limoges, France.
Wolff
M
M
Lachatre
G
G
Boiteau
R
R
Savy
F P
FP
D058186:Acute Kidney Injury / Q000628:therapy; D000666:Amphotericin B / Q000097:blood* / Q000627:therapeutic use; D001980:Bronchi / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D011549:Pseudomonas / Q000187:drug effects / Q000302:isolation & purification; D012121:Respiration, Artificial; D013211:Staphylococcus aureus / Q000187:drug effects / Q000302:isolation & purification; D014031:Tobramycin / Q000097:blood* / Q000627:therapeutic use; D014132:Trachea / Q000737:chemistry
D000666:Amphotericin B; D014031:Tobramycin